SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
SANUWAVE Health, Inc.NASDAQ: SNWV
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents rises 26.8% from a year ago
Cash & equivalents stood at $10.78M at the end of Q1 FY2026, up 26.8% from a year earlier and down 9.9% from the prior quarter. Over 3 fiscal years it compounded at +118.1% a year.
Context
- Cash & equivalents amounted to 29.1% of total assets at the end of Q1 FY2026, up 1.5 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps rising in the next quarterly balance sheet after a +26.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 11.96M USD
- Year-over-year change
- +16.8%
- 4-year CAGR
- +109.7%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.96M | +16.8% |
| FY2024 | 2024-12-31 | 10.24M | +469.7% |
| FY2023 | 2023-12-31 | 1.8M | +55.9% |
| FY2022 | 2022-12-31 | 1.15M | +86.3% |
| FY2021 | 2021-12-31 | 619K | — |
Cash & Equivalents vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's Mar 2026 cash & equivalents of $10.78M is the 10th highest of the 11 companies compared; the peer median is $48.24M.
- Its year-over-year change of +26.8% is the 4th highest of 11, against a peer median of -17.6%.
- Cash & equivalents amounts to 29.1% of total assets for SNWV, versus a peer median of 29.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $94.41M | -20.6% | -17.8% | 33.0% | |
| Mar 2026 | $88.91M | +45.7% | +15.7% | 40.0% | |
| Mar 2026 | $84.96M | -21.9% | -20.8% | 77.4% | |
| Mar 2026 | $67.56M | -14.7% | -15.7% | 36.2% | |
| Dec 2025 | $49.15M | +25.1% | +8.5% | 30.3% | |
| Mar 2026 | $47.32M | +31.9% | +21.0% | 0.0% | |
| Mar 2026 | $36.18M | -52.7% | -55.5% | 9.9% | |
| Mar 2026 | $30.56M | -59.7% | -21.8% | 12.3% | |
| Mar 2026 | $29.93M | -23.9% | +4.2% | 29.1% | |
| Mar 2026 | $10.78M | +26.8% | +118.1% | 29.1% | |
| Mar 2026 | $4.4M | +296.3% | -20.6% | 2.2% | |
| Peer median (excluding SNWV) | $48.24M | -17.6% | -16.8% | 29.7% | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 619K | 1.15M | 1.8M | 10.24M | 11.96M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 2.42M | 4.03M | 3.31M | 3.33M | 5.42M |
| Inventory | 1.04M | 868K | 2.95M | 4.15M | 5.93M |
| Other Current Assets | 0 | 570K | 1.72M | 682K | 1.31M |
| Total Current Assets | 4.4M | 6.62M | 9.78M | 18.4M | 24.63M |
| Property, Plant & Equipment (Net) | 1.01M | 856K | 938K | 732K | 2.36M |
| Goodwill | 7.26M | 7.26M | 7.26M | 7.26M | 7.26M |
| Intangible Assets | 5.84M | 5.14M | 4.43M | 3.73M | 3.03M |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 106K | 0 | 0 | 0 | 68K |
| Total Non-current Assets | 14.22M | 13.25M | 12.63M | 11.72M | 12.72M |
| Total Assets | 18.62M | 19.87M | 22.42M | 30.12M | 37.34M |
| Account Payables | 7.64M | 4.4M | 5.71M | 3.73M | 3.22M |
| Short-term Debt | 27.12M | 38.54M | 29.96M | 25.31M | 5.64M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 48K | 60K | 92K | 193K | 388K |
| Other Current Liabilities | 13.98M | 8.45M | 19.18M | 10.67M | 1.23M |
| Total Current Liabilities | 56.26M | 60.22M | 64.76M | 42.35M | 17.85M |
| Long-term Debt | 875K | 0 | 0 | 0 | 16.32M |
| Deferred Tax Liabilities | 28K | 28K | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 293K | 230K | 347K | 300K | 701K |
| Other Non-current Liabilities | 0 | (28K) | 0 | 0 | 0 |
| Total Non-current Liabilities | 1.31M | 668K | 839K | 491K | 17.88M |
| Total Liabilities | 57.58M | 60.88M | 65.59M | 42.84M | 35.72M |
| Common Stock | 482K | 549K | 3K | 9K | 9K |
| Retained Earnings | (183.95M) | (194.24M) | (220.05M) | (251.42M) | (242.69M) |
| Accumulated OCI | (73K) | (67K) | (111K) | 10K | 10K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (38.96M) | (41.01M) | (43.18M) | (12.72M) | 1.62M |
| Total Debt | 28.39M | 38.98M | 30.45M | 25.5M | 22.97M |
| Net Debt | 27.77M | 37.82M | 28.66M | 15.26M | 11.01M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.